Acquisition Announced

Shionogi & Co. acquisition of Shionogi-Apnimed Sleep Science

US$100m consideration

Announced 29 Apr 2026

Advisers

Shionogi-Apnimed Sleep Science

Target

Shionogi & Co.

Acquirer

Not disclosed

Target
Shionogi-Apnimed Sleep Science
Acquirer
Shionogi & Co.
Seller
Apnimed
Buyer based in
Japan
Seller based in
United States
Stake
50%
Sector
Pharma
Tags
Pharma, Drug Development

In the league tables

Similar deals

All pharma deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.